Princeton Global Asset Management LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Princeton Global Asset Management LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$10,000
-9.1%
1,0000.0%0.00%
-25.0%
Q1 2021$11,000
-26.7%
1,0000.0%0.00%
-20.0%
Q4 2020$15,000
+7.1%
1,0000.0%0.01%
-16.7%
Q3 2020$14,000
+75.0%
1,0000.0%0.01%
+200.0%
Q2 2020$8,000
+100.0%
1,0000.0%0.00%0.0%
Q1 2020$4,0001,0000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 701,138$4,067,0000.67%
Matrix Capital Management Company, LP 2,288,560$13,274,0000.33%
NEA Management Company, LLC 1,250,000$7,250,0000.31%
Stanley-Laman Group, Ltd. 139,403$809,0000.20%
Cormorant Asset Management, LP 500,000$2,900,0000.19%
Tekla Capital Management LLC 468,399$2,717,0000.10%
Wealth Alliance Advisory Group, LLC 21,800$126,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$1,007,0000.03%
Artal Group S.A. 150,000$870,0000.02%
Baker Brothers Advisors 505,262$2,931,0000.02%
View complete list of TRILLIUM THERAPEUTICS INC shareholders